ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
stagbill58
|
35 |
6.4K |
5 |
06:05 |
06:05 |
ASX - By Stock
|
35
|
6.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
stagbill58
|
35 |
6.4K |
23 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
35
|
6.4K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
stagbill58
|
77 |
18K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
9 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1.1K
|
279K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
14 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1.1K
|
279K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
stagbill58
|
55 |
14K |
10 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
10
|
|
ASX - By Stock
|
FSF |
Anyone out there
|
|
stagbill58
|
0 |
58 |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
0
|
58
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
stagbill58
|
196 |
35K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
35K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
stagbill58
|
196 |
35K |
4 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
35K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
stagbill58
|
94 |
23K |
11 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
94
|
23K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
76K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
76K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
76K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
76K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
5 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
76K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
stagbill58
|
311 |
76K |
17 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
311
|
76K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
stagbill58
|
111 |
33K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
33K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
stagbill58
|
209 |
48K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
48K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
10 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
1.1K
|
279K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
stagbill58
|
114 |
32K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
stagbill58
|
114 |
32K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
stagbill58
|
114 |
32K |
15 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
323
|
74K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
12 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
323
|
74K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
12 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.1K
|
279K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
stagbill58
|
45 |
12K |
10 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
45
|
12K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.1K
|
279K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
10 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.1K
|
279K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
stagbill58
|
197 |
51K |
12 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
197
|
51K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
stagbill58
|
1.1K |
279K |
8 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
1.1K
|
279K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
stagbill58
|
197 |
51K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
stagbill58
|
197 |
51K |
10 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
13 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
74K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
8 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
74K
|
8
|
|
ASX - By Stock
|
ANL |
Re:
Ann: AGREEMENT TO ACQUIRE MAJOR LITHIUM RESOURCE IN NEVADA
|
|
stagbill58
|
29 |
20K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
29
|
20K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
8 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
74K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
9 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
74K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
stagbill58
|
323 |
74K |
20 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
74K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
stagbill58
|
430 |
106K |
6 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
430
|
106K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
stagbill58
|
430 |
106K |
16 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
430
|
106K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
stagbill58
|
430 |
106K |
32 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
430
|
106K
|
32
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
stagbill58
|
98 |
23K |
16 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
23K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
stagbill58
|
430 |
106K |
10 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
430
|
106K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stagbill58
|
31K |
15M |
3 |
05/01/24 |
05/01/24 |
Charts
|
31K
|
15M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
stagbill58
|
22K |
11M |
15 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
22K
|
11M
|
15
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stagbill58
|
31K |
15M |
6 |
04/01/24 |
04/01/24 |
Charts
|
31K
|
15M
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
stagbill58
|
31K |
15M |
6 |
04/01/24 |
04/01/24 |
Charts
|
31K
|
15M
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Shareholders as at 29 December 2023
|
|
stagbill58
|
3 |
1.0K |
3 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
stagbill58
|
430 |
106K |
14 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
430
|
106K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
stagbill58
|
56 |
15K |
7 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
56
|
15K
|
7
|
|